Cheshire Medical Center (CMC) in Keene will pay $2 million to resolve allegations that it violated the Controlled Substances Act (CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA deters the illegal distribution, possession, dispensing, and improper use of controlled substances, all of which have contributed to the opioid epidemic. The CSA requires the accurate inventorying, tracking and recordkeeping of each controlled substances to prevent misuse.
The Drug Enforcement Administration (DEA) began an investigation of CMC after a nurse had stolen twenty-three intravenous bags of fentanyl solution from an automatic medication dispensing machine. CMC initially disclosed this theft to the DEA in February 2022. CMC later reported that an additional six hundred thirty-four bags of fentanyl were unaccounted for. The nurse that allegedly stole these drugs died on March 3, 2022. In April 2022, DEA investigators conducted audits of eight controlled substances at CMC’s inpatient pharmacy, which included audits of fentanyl 2ml vial; fentanyl 50 ml vial; fentanyl 50 ml IV bag; midazolam 2ml vial; lorazepam 1ml vial; hydromorphone 4mg tablet; hydromorphone 1 ml vial; and morphine sulfate 1ml vial.
